NCT04714242View on ClinicalTrials.gov

OCTA and Polypoidal Choroidal Vasculopathy

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

December 15, 2020

Study Completion Date

December 20, 2020

Conditions
Polypoidal Choroidal Vasculopathy
Interventions
DRUG

Ranibizumab Injection

Three monthly intravitreal injections of Ranibizumab

Trial Locations (1)

80100

"University of Naples Federico II", Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT04714242 - OCTA and Polypoidal Choroidal Vasculopathy | Biotech Hunter | Biotech Hunter